血症中的CRISPR:全球研究趋势分析
Muhammad Saboor1,2, Maryam Jasem Alblooshi1, Alreem Adel Alkaabi1
1Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Hemoglobin
|March 6, 2026
概括
基因编辑CRISPR显示出治疗β-血病的前景,主要来自美国和中国的研究. 两个主要策略,HBB基因校正和BCL11A抑制导致Casgevy批准,正在推进临床翻译.
科学领域:
- 生物技术是生物技术.
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- β-thalassemia是一种常见的遗传性血液疾病,影响β-环球蛋白链.
- 聚类正规间隔短平行体重复 (CRISPR) 基因组编辑系统提供了一个潜在的治疗方法.
- 图书统计分析对于理解新兴领域的全球研究环境至关重要.
研究的目的:
- 绘制基于CRISPR的β-thalassemia研究的全球研究趋势.
- 确定关键的研究领域,合作和领先的机构.
- 审查CRISPR治疗策略及其转化进展.
主要方法:
- 从最初到现在,对Scopus数据库文章 (原始和复习) 的图书统计分析.
- 搜索术语包括"贝塔血症"和"CRISPR"/"基因编辑"变体.
- VOSviewer软件用于出版物,作者和关键字的网络可视化.
主要成果:
- 基于CRISPR的血病研究显著增长,美国和中国是主要贡献者.
- 确定了两个主要的治疗策略:直接的HBB基因校正和BCL11A抑制用于胎儿血红蛋白重新激活.
- 基于BCL11A抑制的Exagamglogene autotemcel (Casgevy) 获得了监管部门的批准.
结论:
- 对血症的CRISPR研究正在从基础科学向临床应用过渡.
- 国际合作广泛,推动基因编辑疗法的进步.
- 未来的实施需要生物处理,降低成本和适应性医疗保健模型的进步.
相关概念视频
CRISPR
58.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.5K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
Homologous Recombination
64.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.7K


